EUVIMEDEUVIMED entdecken
Crossref

Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP

Abeer Salama, Sahar Abd Elwahab, Amany A El-Fadaly

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.116367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Abeer Salama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, National Research Centre, El- Buhouth St., Dokki, Cairo 12622, Egypt. Hauptthemen laut MEDLINE: Schizophrenia, Gallic Acid. Die Arbeit nennt 78 Literaturangaben. Gefördert von: National Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia is a highly debilitating mental disorder characterized by a variety of neurodevelopmental and behavioral issues. There is mounting evidence that neuroinflammation and myelin deficiency are the coexisting pathological features that lead to schizophrenia. Thus, the current work investigated the therapeutic potential of syringic acid (SA) in ameliorating neuroinflammation and demyelination in a mouse model of cuprizone (CPZ)-induced schizophrenia. Schizophrenia in mice was induced by 0.2% CPZ in diet for 6 weeks. Male Swiss mice were randomly divided into four groups: 1st group: Normal control group received normal chow for 6 weeks, 2nd group: CPZ, 3rd Group: Mice received CPZ + SA (50 mg/kg; orally). 4th group: Mice received CPZ + SA (100 mg/kg; orally). Our results showed that CPZ induced behavioral, biochemical, molecular and histopathological changes, while SA significantly alleviated behavioral abnormalities induced by CPZ. Furthermore, SA increased Pi form of glutathione-S-transferase (GST-π), myelin basic protein (MBP), neuregulin-1 (NRG-1), protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3k), and protein kinase B (Akt1). Additionally, it lessened glial fibrillary acidic protein (GFAP), galectin-3, glycogen synthase kinase 3 beta (GSK-3β), and tumor necrosis factor-α (TNF-α). Moreover, SA relieved histopathological alterations in the brain induced by CPZ. The above findings suggest that SA could ameliorate CPZ-induced psychotic symptoms in mice via suppressing neuroinflammation and promoting myelin integrity, perhaps providing further benefits to people suffering from schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaGallic AcidAnimalsMaleGlycogen Synthase Kinase 3 betaSignal TransductionProto-Oncogene Proteins c-aktMiceMyelin Basic ProteinPhosphatidylinositol 3-KinasesGalectin 3Disease Models, AnimalCuprizoneBrain

Stichwörter der Autor:innen

CuprizoneGalectin-3MBPMiceSchizophrenia

Substanzen

Glycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktMyelin Basic Proteinsyringic acidPhosphatidylinositol 3-KinasesGalectin 3Gallic AcidCuprizoneLgals3 protein, mouseGsk3b protein, mouse

Autor:innen und Institutionen

  • Pharmacology Department, National Research Centre, El- Buhouth St., Dokki, Cairo 12622, Egypt.
  • Medical Biochemistry and Molecular Biology Department, Faculty of Medicine Cairo University Al Kasr Al Aini, Old Cairo, Cairo, Governorate, Egypt.
  • Pharmacology Department, National Research Centre, El- Buhouth St., Dokki, Cairo 12622, Egypt. Electronic address: amany_elfadaly@yahoo.com.

Förderung

  • National Research Centre

Zitieren

APA

Salama, A., Elwahab, S. A., & El-Fadaly, A. A. (2026). Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116367

Vancouver

Salama A, Elwahab SA, El-Fadaly AA. Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116367

BibTeX
@article{Salama2026,
  author = {Salama, Abeer and Elwahab, Sahar Abd and El-Fadaly, Amany A},
  title = {Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.116367}
}
Kostenlos starten →